Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review

Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary brain tumor in adults. The etiology of GBM is not known, and the prognosis is usually very poor. Despite new diagnostic techniques and treatment methods, the management of patients with GBM is difficult.